Andrew P. Reding's most recent trade in Predictive Oncology Inc was a trade of 3,049 Stock Options (right to buy) done . Disclosure was reported to the exchange on June 30, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Predictive Oncology Inc | Andrew P. Reding | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 3,049 | 3,049 | - | - | Stock Options (right to buy) | |
Predictive Oncology Inc | Andrew P. Reding | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 4,070 | 4,076 (0%) | 0% | - | Common Stock, $.01 par value |